Document Detail

PICS-ure this: prosenescence therapy?
MedLine Citation:
PMID:  20227036     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Senescence is increasingly recognized as a critical feature of mammalian cells to suppress tumorigenesis, acting together with cell death programs. Whether senescence, like programmed cell death, can be exploited therapeutically has been unclear. Pandolfi and coworkers now propose that PTEN-loss-induced cellular senescence (PICS) may be triggered in vivo for therapy.
Daniel S Peeper
Related Documents :
9494546 - Systematic determination of telomerase activity and telomerase length during the progre...
18565326 - Impaired response to oxidative stress in senescent cells may lead to accumulation of dn...
20633556 - A cajal body-independent pathway for telomerase trafficking in mice.
19415276 - Downregulation of telomerase activity in human promyelocytic cell line using rna interf...
22233946 - Newcastle disease virus lasota strain kills human pancreatic cancer cells in vitro with...
9811976 - Alteration of cell fate by ectopic expression of drosophila glial cells missing in non-...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cancer cell     Volume:  17     ISSN:  1878-3686     ISO Abbreviation:  Cancer Cell     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-15     Completed Date:  2010-06-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130617     Medline TA:  Cancer Cell     Country:  United States    
Other Details:
Languages:  eng     Pagination:  219-20     Citation Subset:  -    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
The Netherlands Cancer Institute, Division of Molecular Genetics, 1066 CX Amsterdam, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The rebirth of a phoenix: ovarian cancers are addicted to ErbB-3.
Next Document:  The Raf Inhibitor Paradox: Unexpected Consequences of Targeted Drugs.